A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1999
12/28/1999	US6007774 Administering a biocompatible non-blood oxygen carrier while monitoring one or more oxygenation indices to maintain oxygenation of the patient's tissues at or above a predetermined level
12/28/1999	US6006753 Therapy
12/28/1999	US6006752 Mixed chimerism and tolerance
12/28/1999	CA2191862C Branched synthetic peptide conjugate
12/28/1999	CA1340866C Human c3b/c4b receptor (cr1)
12/28/1999	CA1340862C Method of producing a human protein and dna-sequence for use when carrying out the method
12/28/1999	CA1340861C Cysteine-depleted muteins of biologically active proteins
12/23/1999	WO1999066073A1 METHOD FOR SCREENING Pax4 GENE EXPRESSION POTENTIATOR AND MEDICINAL COMPOSITIONS FOR POTENTIATING Pax4 GENE EXPRESSION
12/23/1999	WO1999066065A2 Proteasomal activity
12/23/1999	WO1999066054A2 Erythropoietin analog-human serum albumin fusion protein
12/23/1999	WO1999066051A2 Nek-related and bub1-related protein kinases
12/23/1999	WO1999066049A2 A novel gene and method of treating a gram negative bacterial infection
12/23/1999	WO1999066048A1 A mutant human hepatitis b viral strain and uses thereof
12/23/1999	WO1999066047A1 A vaccine-induced hepatitis b viral strain and uses thereof
12/23/1999	WO1999066044A1 Bactericidal/permeability-increasing protein (bpi) deletion analogs
12/23/1999	WO1999066043A1 Recombinant production of toxoplasma sag1 antigen
12/23/1999	WO1999066041A1 94 human secreted proteins
12/23/1999	WO1999066039A1 Tnfr-like protein with death domain
12/23/1999	WO1999066038A1 Angiostatin-binding protein
12/23/1999	WO1999066037A2 Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation
12/23/1999	WO1999066036A1 Transplants for myocardial scars
12/23/1999	WO1999066031A2 Pharmaceutical factor vii preparation
12/23/1999	WO1999066027A1 Monoclonal antibodies that recognize antigens associated with tumor metastasis
12/23/1999	WO1999065948A1 Variant type ii tgf-beta receptor fusion proteins and methods
12/23/1999	WO1999065947A2 Monoclonal antibodies directed against the g3bp protein, and uses
12/23/1999	WO1999065944A1 PEPTIDE INHIBITORS OF αVβ3 AND αVβ¿5?
12/23/1999	WO1999065942A1 Cyclic somatostatin analogs
12/23/1999	WO1999065941A1 Insulin analogue
12/23/1999	WO1999065940A1 Anti-angiogenic proteins and methods of use thereof
12/23/1999	WO1999065939A1 INTERACTION OF p27(KIP1) WITH FKBP-12
12/23/1999	WO1999065936A2 Composition for the treatement of immune deficiencies and methods for its preparation and use
12/23/1999	WO1999065934A1 Antithrombotic compounds
12/23/1999	WO1999065933A1 Novel cyclosporins
12/23/1999	WO1999065932A1 Tetrapeptides, analogs and peptidomimetics which bind selectively mammalian opioid receptors
12/23/1999	WO1999065929A1 Exons 4 and 7 encode separate transactivating and chromatin localizing domains in esx
12/23/1999	WO1999065928A2 Polynucleotide population isolated from non-metastatic and metastatic breast tumor tissues
12/23/1999	WO1999065924A2 Preparation and use of superior vaccines
12/23/1999	WO1999065922A2 Prenyl transferase inhibitors
12/23/1999	WO1999065866A1 Anthracene derivatives as anti-cancer agents
12/23/1999	WO1999065712A2 Glycosulfopeptides and methods of synthesis and use thereof
12/23/1999	WO1999065530A1 NrdD
12/23/1999	WO1999065524A1 LZ-CD23 CHIMERA FOR INHIBITION OF IgE-MEDIATED ALLERGIC DISEASE
12/23/1999	WO1999065522A1 Hla binding peptides and their uses
12/23/1999	WO1999065519A1 Matrix metalloproteinase proenzyme activator
12/23/1999	WO1999065517A2 Therapeutic compositions that produce an immune response by altering the antigen
12/23/1999	WO1999065516A1 Methods and compositions for treating diseases mediated by transglutaminase activity
12/23/1999	WO1999065515A2 Combination of radiotherapy and anti-angiogenic factors
12/23/1999	WO1999065514A1 Protease containing hairball remedy and use thereof
12/23/1999	WO1999065513A2 Pharmaceutical compositions for the treatment of helicobacter pylori-associated disorders
12/23/1999	WO1999065512A1 Medicinal compositions containing fibroblast growth factor-related peptides
12/23/1999	WO1999065511A2 Composition and method for treatment of pseudomonas infection
12/23/1999	WO1999065510A1 Crosslink-stabilized indolicidin analogs
12/23/1999	WO1999065509A1 Regulation of tyrosine hydroxylase
12/23/1999	WO1999065508A1 Conformationally constrained backbone cyclized somatostatin analogs
12/23/1999	WO1999065507A1 Modulating platelet function
12/23/1999	WO1999065506A2 Cancer therapy with indolicidin or cationic peptides and their polymer conjugates
12/23/1999	WO1999065502A1 Oligonucleotides for enhanced modulation of protein kinase c expression
12/23/1999	WO1999065500A1 Preventing cerebral infarction through administration of adp-receptor antiplatelet and antihypertensive drugs in combination
12/23/1999	WO1999065482A1 Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone
12/23/1999	WO1999065470A1 Particulate acellular tissue matrix
12/23/1999	WO1999065469A2 Processes to generate submicron particles of water-insoluble compounds
12/23/1999	WO1999065463A1 Active ingredient delivery systems and devices based on porous matrices
12/23/1999	WO1999065450A2 Immunosuppressive agents that inhibit calcineurin function and uses thereof
12/23/1999	WO1999065329A2 Dietary supplement containing colostrinin
12/23/1999	WO1999065299A1 Compositions and methods for expansion of hematopoietic cells
12/23/1999	WO1999055728A3 Ese genes and proteins
12/23/1999	WO1999053043A3 Herpes simplex virus latency associated transcript polypeptides
12/23/1999	WO1999051741A3 Lyst protein complexes and lyst interacting proteins
12/23/1999	WO1999050398A3 Recombinant anti-tumor rnase
12/23/1999	WO1999049881A3 Application of hsp70 proteins
12/23/1999	WO1999047558A3 T cell costimulatory proteins, sequences and uses thereof
12/23/1999	WO1999047097B1 Material composition for the formation of tissue
12/23/1999	WO1999045098A3 Delivery or proteins into eukaryotic cells with recombinant yersinia
12/23/1999	WO1999042578A3 Modulation of cell proliferation, methods and reagents
12/23/1999	WO1999039722A3 Compositions and methods for separating lens epithelial cells and preventing posterior capsular opacification
12/23/1999	WO1999033869A3 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
12/23/1999	DE19852804C1 Pharmaceutical composition for manipulating angiogenesis
12/23/1999	DE19826972A1 Inhibiting keratinocyte activation and proliferation, for treatment of dermatological disorders such as psoriasis or actinic precancerous states
12/23/1999	DE19822122A1 Humane deadenylierende Nuclease, ihre Herstellung und Verwendung Human deadenylierende nuclease, their preparation and use
12/23/1999	DE19812375C1 Für Tumorsuppressorproteine codierende Nucleinsäure, Tumorsuppressorproteine, Verfahren zu deren Herstellung, Antikörper gegen Tumorsuppressorproteine und Verwendung dieser Gegenstände For nucleic acid coding for tumor suppressor proteins, tumor suppressor proteins, processes for their preparation, to antibodies against tumor suppressor proteins and use of these articles
12/23/1999	CA2337603A1 Prenyl transferase inhibitors
12/23/1999	CA2335650A1 Crosslink-stabilized indolicidin analogs
12/23/1999	CA2335452A1 Preparation and use of superior vaccines
12/23/1999	CA2335248A1 Transplants for myocardial scars
12/23/1999	CA2335184A1 Cyclic somatostatin analogs
12/23/1999	CA2335078A1 Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone
12/23/1999	CA2335038A1 Combination of radiotherapy and anti-angiogenic factors
12/23/1999	CA2334996A1 Active ingredient delivery systems and devices based on porous matrices
12/23/1999	CA2334859A1 Insulin analogue
12/23/1999	CA2334797A1 Anthracene derivatives as anti-cancer agents
12/23/1999	CA2334528A1 Regulation of tyrosine hydroxylase
12/23/1999	CA2333221A1 Therapeutic compositions that produce an immune response by altering the antigen
12/23/1999	CA2332563A1 Glycosulfopeptides and methods of synthesis and use thereof
12/23/1999	CA2332173A1 A vaccine-induced hepatitis b viral strain and uses thereof
12/23/1999	CA2331889A1 Nek-related and bub1-related protein kinases
12/23/1999	CA2331880A1 Bactericidal/permeability-increasing protein (bpi) deletion analogs
12/23/1999	CA2331834A1 Pharmaceutical compositions for the treatment of helicobacter pylori-associated disorders
12/23/1999	CA2331382A1 Interaction of p27(kip1) with fkbp-12
12/23/1999	CA2331332A1 Anti-angiogenic proteins and methods of use thereof
12/23/1999	CA2331266A1 Exons 4 and 7 encode separate transactivating and chromatin localizing domains in esx

1 ... 2440 2441 2442 2443 2444 2445 2446 2447 2448 2449 2450 2451 2452 2453 2454 2455 2456 2457 2458 2459 2460 ... 3163